Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TAGI Pharma is a specialty pharmaceutical company that focuses on the development, marketing, and distribution of generic and branded prescription drug products. Based in South Beloit, Illinois, the company provides a diverse portfolio of products across various therapeutic areas, including pain management, anti-infectives, and cardiovascular health. TAGI Pharma was acquired by Lannett Company in 2018 to expand its product offerings and distribution capabilities. The company operates as a subsidiary, leveraging its expertise in supply chain management and commercialization to deliver cost-effective healthcare solutions. Its business model emphasizes strategic partnerships and a lean operational structure to maintain competitiveness in the generic market. Today, TAGI Pharma continues to serve the U.S. healthcare market by providing high-quality, affordable medication to patients and providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tagi.